Portugal's public healthcare grows but struggles with unequal access and funding gaps
Portugal's public healthcare grows but struggles with unequal access and funding gaps
Portugal's public healthcare grows but struggles with unequal access and funding gaps
Portugal's National Health Service (SNS) has seen a sharp rise in users over the past decade. By September 2025, registrations reached 10.7 million—an increase of over 522,000 since 2015. Yet despite this growth, many citizens still struggle to navigate the system effectively.
The surge in SNS users stems from several factors: a growing population, higher immigration, longer life expectancy, and greater demand for public healthcare. However, access remains uneven across regions. The North and Lisbon and Tagus Valley areas hold the highest concentrations of users, while rural zones like Alentejo and Algarve lag behind.
Medical staffing has also expanded. The number of doctors per 1,000 inhabitants climbed from 1.1 in 2015 to 2.1 in 2025, with the North surpassing the national average. Similarly, nurse density rose from 2.9 to 5.0 per 1,000 people over the same period. These regional differences reflect uneven physician retention, medical school placements, and EU-funded investments favouring urban areas in the north.
Despite improvements, challenges persist. Half of respondents report difficulties getting a response when contacting the SNS. Only 47% of Portuguese know where to go in a medical emergency. Meanwhile, 35.4% now hold dual coverage, using both the SNS and private insurance.
Funding remains a concern. Portugal's per capita health spending sits nearly 20% below the EU average, even after a 5% increase between 2023 and 2024.
The SNS now serves 10.7 million people, with more doctors and nurses than a decade ago. But regional gaps, underfunding, and public confusion over emergency care continue to test the system. Dual coverage is also on the rise, suggesting some are turning to private options for faster access.
Taiwan battles early flu surge and rising dengue fever cases ahead of holidays
A perfect storm of flu and dengue hits Taiwan just as holidays approach. Could crowded gatherings worsen the outbreak?
Johnson & Johnson defies market slump with 15% stock surge in 2024
A pharma giant thrives where others falter. How J&J's billion-dollar drugs and smart spin-offs outperform a volatile market.
India warns Pakistan over Sir Creek with military show of strength
A sacred weapon ritual and a bold warning: India flexes its military muscle as tensions rise over the unresolved Sir Creek border. What happens next?
Guernsey's life-saving cholesterol screening earns national award nomination
A tiny island's bold health initiative is saving lives—and catching national attention. Could this cholesterol screening model reshape care across the UK?